🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
9.95
-0.62 (-5.87%)
At close: Nov 20, 2026, 4:00 PM EST
10.07
+0.12 (1.21%)
After-hours: Nov 20, 2026, 7:54 PM EST

Summit Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7,95813,48713,1601,829897263
Market Cap Growth
-35.45%2.49%619.43%103.94%241.23%-32.01%
Enterprise Value
7,34813,25412,7051,737779184
Last Close Price
9.9517.4917.842.614.252.69

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----1272.24145.30
PB Ratio
14.0920.4733.8523.547.083.16
P/TBV Ratio
14.1420.5334.0224.137.183.71

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
----1105.42101.96

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.040.030.021.374.100.03
Net Debt / Equity Ratio
-1.08-1.05-1.04-1.031.34-0.83
Net Debt / EBITDA Ratio
0.710.631.920.91-2.730.81
Net Debt / FCF Ratio
1.162.142.851.04-4.030.95
Asset Turnover
----0.000.02
Quick Ratio
5.719.789.889.179.153.47
Current Ratio
5.999.8710.159.3016.933.80
Return on Equity (ROE)
-220.01%-206.10%-94.89%-601.85%-75.05%-108.89%
Return on Assets (ROA)
-174.46%-181.94%-69.32%-141.83%-20.26%-82.09%
Return on Capital Employed (ROCE)
-146.80%-161.40%-53.60%-48.60%-10.20%-98.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-10.73%-8.00%-1.68%-33.62%-8.78%-33.71%
FCF Yield
-6.62%-2.40%-1.08%-4.20%-4.71%-27.73%
Buyback Yield / Dilution
-5.30%-4.06%-15.96%-220.50%-109.60%-32.67%
SEC Filings: 10-K · 10-Q